Hyperkalaemia: aetiology, epidemiology, and clinical significance

por Tromp, Jasper, van der Meer, Peter
Publicado 2019

Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering

por Hoes, Martijn F., Bomer, Nils, van der Meer, Peter
Publicado 2018

Prognostic value of galectin-3, a novel marker of fibrosis

por Lok, Dirk J., Bruggink, Pieta W., van der Meer, Peter
Publicado 2010

Urinary sodium evaluation: the missing target for diuretic treatment optimization in acute heart failure patients? Reply

por Damman, Kevin, Ter Maaten, Jozine M., van der Meer, Peter
Publicado 2020

Selenium, Selenoproteins, and Heart Failure: Current Knowledge and Future Perspective

por Al-Mubarak, Ali A., van der Meer, Peter, Bomer, Nils
Publicado 2021

Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del

por Deiman, Frederik E., Bomer, Nils, van der Meer, Peter, Grote Beverborg, Niels
Publicado 2022

Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues

por Bracun, Valentina, Aboumsallem, Joseph Pierre, van der Meer, Peter, de Boer, Rudolf A.
Publicado 2020

Treating oxidative stress in heart failure: past, present and future

por van der Pol, Atze, van Gilst, Wiek H., Voors, Adriaan A., van der Meer, Peter
Publicado 2018

Cancer and heart disease: associations and relations

por de Boer, Rudolf A., Meijers, Wouter C., van der Meer, Peter, van Veldhuisen, Dirk J.
Publicado 2019

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology

por Alnuwaysir, Ridha I. S., Hoes, Martijn F., van Veldhuisen, Dirk J., van der Meer, Peter, Beverborg, Niels Grote
Publicado 2021

ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants

por Klaassen, Sebastiaan, Tromp, Jasper, Hazenberg, Bouke, Van Veldhuisen, Dirk-Jan, Van Den Berg, Maarten, Van Der Meer, Peter
Publicado 2015

Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived Cardiomyocytes

por Kijlstra, Jan David, Hu, Dongjian, Mittal, Nikhil, Kausel, Eduardo, van der Meer, Peter, Garakani, Arman, Domian, Ibrahim J.
Publicado 2015

Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease

por Eisenga, Michele F., Nolte, Ilja M., van der Meer, Peter, Bakker, Stephan J. L., Gaillard, Carlo A. J. M.
Publicado 2018

Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations

por Vegter, Eline L., Ovchinnikova, Ekaterina S., van Veldhuisen, Dirk J., Jaarsma, Tiny, Berezikov, Eugene, van der Meer, Peter, Voors, Adriaan A.
Publicado 2017

Functional Differences in Engineered Myocardium from Embryonic Stem Cell-Derived versus Neonatal Cardiomyocytes

por Feinberg, Adam W., Ripplinger, Crystal M., van der Meer, Peter, Sheehy, Sean P., Domian, Ibrahim, Chien, Kenneth R., Parker, Kevin Kit
Publicado 2013

Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure

por Beusekamp, Joost C., Tromp, Jasper, Boorsma, Eva M., Heerspink, Hiddo J.L., Damman, Kevin, Voors, Adriaan A., van der Meer, Peter
Publicado 2021

Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?

por Bomer, Nils, Pavez‐Giani, Mario G., Grote Beverborg, Niels, Cleland, John G. F., van Veldhuisen, Dirk J., van der Meer, Peter
Publicado 2022

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

por Voorrips, Suzanne N., Saucedo-Orozco, Huitzilihuitl, Sánchez-Aguilera, Pablo I., De Boer, Rudolf A., Van der Meer, Peter, Westenbrink, B. Daan
Publicado 2022

Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes

por Ovchinnikova, Ekaterina, Hoes, Martijn, Ustyantsev, Kirill, Bomer, Nils, de Jong, Tristan V., van der Mei, Henny, Berezikov, Eugene, van der Meer, Peter
Publicado 2018

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?

por Klaassen, Sebastiaan HC, van Veldhuisen, Dirk J, Nienhuis, Hans LA, van den Berg, Maarten P, Hazenberg, Bouke PC, van der Meer, Peter
Publicado 2020